Form 4: Alphatec Holdings Executive Receives Significant RSU Grants Following Performance Review

Craig E. Hunsaker, EVP of People & Culture at Alphatec Holdings, received multiple grants of restricted stock units (RSUs) totaling 352,061 shares, linked to performance and a bonus election.

Summary

• Craig E. Hunsaker, EVP of People & Culture at Alphatec Holdings, was granted a total of 352,061 restricted stock units (RSUs) on January 29, 2025.
• 156,935 RSUs were awarded based on the company's compensation committee confirming the satisfaction of performance criteria for the fiscal year ended December 31, 2024.
• These performance-based RSUs will vest in three equal installments on March 5, 2025, March 5, 2026, and March 5, 2027.
• An additional 173,417 RSUs were granted, vesting in three equal installments on March 5, 2026, March 5, 2027, and March 5, 2028.
• 21,709 RSUs were granted in lieu of a portion of Hunsaker's 2024 cash bonus, vesting on December 5, 2025.
• The grant amount for the bonus RSUs was determined using the 30-day average trading price of Alphatec's common stock as of the market close on January 24, 2025.
• Each RSU represents a contingent right to receive one share of Alphatec's common stock.

Sentiment

Score: 7

Explanation: The document reflects a positive event for the executive and implies confidence in the company's performance, but it is a routine filing and not a major market-moving event.

Positives

• The RSU grants indicate a positive performance review for the executive.
• The vesting schedule of the RSUs aligns the executive's interests with the long-term performance of the company.
• The grant of RSUs in lieu of cash bonus suggests a confidence in the company's future stock performance.

Risks

• The value of the RSUs is subject to the volatility of the company's stock price.
• The vesting of the RSUs is contingent on the executive's continued employment with the company.

Future Outlook

The document does not contain any specific forward-looking statements, but the vesting schedule of the RSUs suggests a long-term incentive for the executive.

Industry Context

The granting of RSUs is a common practice in the industry to incentivize and retain key executives. The vesting schedule is typical for such grants.

Comparison to Industry Standards

• RSU grants are a standard form of executive compensation across the medical device and technology industries.
• Vesting schedules of three to four years are common, aligning executive interests with long-term company performance.
• Companies like Medtronic, Stryker, and Johnson & Johnson also use similar equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders may view the RSU grants as a positive sign of management's commitment to the company's long-term success.
• Employees may see the grants as a positive indicator of the company's financial health and commitment to its leadership.

Next Steps

• The executive will receive shares of common stock as the RSUs vest according to the specified schedule.

Key Dates

Keywords

RSU, Restricted Stock Units, Executive Compensation, Stock Grant, Alphatec Holdings, ATEC, Performance Based Compensation, Equity Award, Vesting Schedule